Passive

First Trust International Developed Capital Strength ETF

The First Trust International Developed Capital Strength® ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an index called The International Developed Capital Strength IndexTM (the "Index").

$41.25

Key Metrics

TER 0.70% per year
Distribution policy Distributing
Fund size USD 215 M
Inception date December 15, 2020
Holdings 52
Fund currency USD
Fund domicile US
Provider First Trust
For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
International Developed Capital Strength ETF FICS
Fund Size
$216M
Dividend
1.9%
Fees
0.70%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFIAX
Fund Size
$1.67T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.67T
Dividend
0.9%
Fees
-
View 1341 similar ETFs →

Historical Return

Last updated: Sep 01, 2026
1 Year +10.6% +1.9% Div
3 Years (avg.) +10.1% +1.9% Div
5 Years (avg.) +3.0% +1.9% Div

Risk & Analysis Metrics

Last updated: Sep 01, 2026

Volatility

12.33% 1 Year
12.95% 3 Years
16.93% 5 Years
16.66% 10 Years

Max Drawdown

-10.77% 1 Year
-11.50% 3 Years
-30.37% 5 Years
-30.37% 10 Years

Sharpe Ratio

0.45 1 Year
0.44 3 Years
0.00 5 Years
0.18 10 Years

Return Triangle (Heatmap)

Last updated: Sep 01, 2026
2020 2021 2022 2023 2024 2025
2020 2.2% 9.0% -2.1% 2.2% 2.1% 4.7%
2021 16.3% -4.2% 2.2% 2.1% 5.2%
2022 -21.1% -4.1% -2.3% 2.6%
2023 16.4% 8.8% 11.9%
2024 1.6% 9.7%
2025 18.5%

Distributions

*by ETF Portfolio Weight Last updated: Sep 01, 2026

Profit Margin Distribution

< 0%
5%
1y 3y N/A N/A
0 - 5%
7%
1y 3y N/A N/A
5 - 10%
21%
1y 3y N/A N/A
10 - 15%
19%
1y 3y N/A N/A
15 - 20%
25%
1y 3y N/A N/A
20 - 30%
7%
1y 3y N/A N/A
30 - 40%
4%
1y 3y N/A N/A
> 40%
13%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
6%
1y 3y N/A N/A
0 - 10
9%
1y 3y N/A N/A
10 - 15
21%
1y 3y N/A N/A
15 - 20
16%
1y 3y N/A N/A
20 - 25
27%
1y 3y N/A N/A
25 - 35
7%
1y 3y N/A N/A
35 - 50
3%
1y 3y N/A N/A
> 50
11%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
9.6%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
12.0%
1y 3y N/A N/A
Large Cap
54.2%
1y 3y N/A N/A
Mega Cap
24.2%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Sep 01, 2026
20.2% Top 5 Holdings
37.9% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
IMO Imperial Oil Ltd.
4.7%
RIO Rio Tinto plc
4.2%
BHP BHP Group Limited
3.9%
GSK Glaxosmithkline plc
3.9%
ST Sensata Technologies Holding Plc
3.6%

Latest News

3 months ago • wsj.com

After shedding its cancer business just over a decade ago, GSK's new CEO is building back with a $10.6 billion deal

After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal.

3 months ago • zacks.com

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study

Gilead and Merck report positive phase III results for once-weekly HIV regimen islatravir/lenacapavir, while ending a lung cancer study.

3 months ago • zacks.com

GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout

GSK buys Nuvalent for $10.6 billion, adding three lung cancer pipeline candidates and expanding its precision oncology presence.

Average metrics of all companies in portfolio

Last updated: Sep 13, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $102B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.83% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.79 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 27.42 22.99
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -18.81 -
Profitable Companies 95% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 28.3 18.8
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 2.74 9.13
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.16 11.88
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 8.36 12.43
Enterprise Value to Revenue Enterprise value divided by revenue 4.54 12.4
Total Debt to Enterprise Value Total debt divided by enterprise value 0.22 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.79 0.32
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 17.01% 21.44%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +23.8% +54.3%
Return on Equity Equity divided by market cap. 16.47% 2.03%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.46% 4.04%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 11.76% 3.73%

Sectors

Finance and Insurance 15.1%
Manufacturing 11.9%
Mining, Quarrying, and Oil and Gas Extraction 8.0%
Health Technology 3.8%
Transportation and Warehousing 2.1%
Consumer Non-Durables 2.0%
Professional, Scientific, and Technical Services 1.8%
Information 1.7%
Other 53.6%

Countries

Switzerland 25.8%
Canada 18.7%
United Kingdom 11.5%
Other 11.1%
France 5.6%
Australia 4.1%
Germany 4.0%
Spain 3.9%
Finland 3.7%
Sweden 3.6%
Italy 2.4%
Netherlands 2.1%
Ireland 1.8%
Japan 1.7%

Stock Screener

Select filters to narrow down the 26 investments below

26 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Loading details…

Market Cap $65.31B
P/E Ratio 5.0
Dividends 1.7%
Total Investment $5.11M
Weight 2.37%

Loading details…

Market Cap $286.16B
P/E Ratio 17.9
Dividends 2.3%
Total Investment $4.93M
Weight 2.29%

Loading details…

Market Cap $204.38B
P/E Ratio 17.9
Dividends 2.6%
Total Investment $4.91M
Weight 2.28%

Loading details…

Loading details…

Loading details…

Market Cap $69.02B
P/E Ratio 34.8
Dividends 1.2%
Total Investment $4.76M
Weight 2.21%

Loading details…

Loading details…

Market Cap $106.23B
P/E Ratio 15.1
Dividends 2.6%
Total Investment $4.48M
Weight 2.08%

Loading details…

Market Cap $5.01B
P/E Ratio 25.7
Dividends 0.0%
Total Investment $4.46M
Weight 2.07%

Loading details…

Loading details…

Market Cap $133.61B
P/E Ratio 20.6
Dividends 3.6%
Total Investment $4.38M
Weight 2.03%

Loading details…

Market Cap $8.87B
P/E Ratio 14.2
Dividends 2.9%
Total Investment $4.37M
Weight 2.03%

Loading details…

Market Cap $261.86B
P/E Ratio 20.8
Dividends 3.3%
Total Investment $4.37M
Weight 2.03%

Loading details…

Market Cap $22.39B
P/E Ratio 13.3
Dividends 0.2%
Total Investment $4.31M
Weight 2.00%

Loading details…

Market Cap $39.21B
P/E Ratio 16.1
Dividends 0.9%
Total Investment $4.27M
Weight 1.98%

Loading details…

Loading details…

Loading details…

Market Cap $97.65B
P/E Ratio
Dividends 5.0%
Total Investment $3.98M
Weight 1.85%

Loading details…

Loading details…